Nigeria expects to take delivery of 29 million doses of US pharmaceutical company Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine in August 2021, Reuters news agency reported on Tuesday.
Health Minister Osagie Ehanire was quoted as telling reporters that the single-dose vaccine would be "advantageous" for Nigeria given its partly nomadic population and weak systems for keeping track of people and arranging for second doses.
Ehanire said Nigeria was also expecting four million doses of the Moderna vaccine, 700,000 doses of the AstraZeneca vaccine and an unspecified quantity of Pfizer and Sinopharm doses.
All of these are expected in the third quarter.
According to the most recent data in June 2021, two million people in Nigeria had received one COVID-19 vaccine dose and 700,000 had received two.
So far, in total, Nigeria has so far taken delivery of just under four million vaccine doses.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses